| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.03. | Procept BioRobotics announces international Hydros robot launch | ||
| 12.03. | XCath raises $30M Series C to support endovascular robot, Dr. Fred Moll co-leads round | ||
| 12.03. | Johnson & Johnson wins FDA nod for new intraocular lens | ||
| 12.03. | Abbott study highlights better glucose outcomes with Libre CGM in type 2 diabetes on basal insulin | ||
| 12.03. | Chinese ultrasound-based BCI startup Gestala raises $21.7M | ||
| 11.03. | Insulet shares study outcomes supporting fully closed-loop insulin pump for type 2 diabetes | ||
| 11.03. | Stryker reportedly hit with Iran-backed cyberattack | ||
| 11.03. | Verve Medical treats first patient in study of pelvic denervation for hypertension | ||
| 11.03. | Olympus launches next-gen surgical imaging platform | ||
| 11.03. | Noah Medical study backs real-time imaging guidance in robotic bronchoscopy | ||
| 11.03. | Incisionless surgical robot developer Petal Surgical adds more funding, Fred Moll joins board | ||
| 11.03. | Karl Storz wins FDA nod for single-use bronchoscope | ||
| 10.03. | Medtronic names Sean Haag president of ENT business | ||
| 10.03. | Cook Medical launches new endoscopy products | ||
| 10.03. | Cook Medical launches iMRI center at Indiana University | ||
| 10.03. | Smith+Nephew launches next-gen foam dressing for wound management, pressure injury | ||
| 10.03. | MiniMed picks up CE mark for MiniMed 780G pump with Instinct sensor made by Abbott | ||
| 10.03. | CamDiab introduces fully closed-loop automated insulin delivery tech | ||
| 10.03. | Medtronic data highlights clinical benefit of Symplicity Spyral renal denervation | ||
| 10.03. | OncoPatch wins FDA nod for tumor-treating patch device | ||
| 10.03. | HeartBeam, Mount Sinai ink strategic AI collab to bring heart monitoring into the home | ||
| 10.03. | Medtronic makes neurovascular play with $550M Scientia Vascular buy | ||
| 09.03. | Abbott completes $20B offering for Exact Sciences buy | ||
| 09.03. | MiniMed completes $538M IPO, retains $309M in proceeds as Medtronic separation takes shape | ||
| 09.03. | Stereotaxis expects growth in 2026 with manufacturing ramp for new products |